The Valley Desk

NCT07214532 · Interventional trial

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Overall registry status Recruiting

Conditions Breast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (for ER-positive Requirement)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov